Therapeutic options for COVID-19: a quick review

MS Ismaila, F Bande, A Ishaka, AA Sani… - Journal of …, 2020 - Taylor & Francis
Since the announcement by the World Health Organization (WHO) of an outbreak of a
contagious respiratory viral pneumonia in Wuhan, China, in December 2019 (later named …

Pharmacological treatments of COVID-19

A Sahebnasagh, R Avan, F Saghafi… - Pharmacological …, 2020 - Springer
The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19),
which was reported for the first time in December 2019, was named by the World Health …

Advances in the possible treatment of COVID-19: A review.

P Chibber, SA Haq, I Ahmed, NI Andrabi… - European journal of …, 2020 - Elsevier
The emergence of the global pandemic caused by novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …

[PDF][PDF] Pharmacological treatments of covid-19-a review

JM Cherumanalil, J Thayyil - Asian J Pharm Clin Res, 2020 - kmctmedicalcollege.org
Now the world stands in the fight against coronavirus disease 2019 (COVID-19), with its
early origin from Wuhan city in China. It has evolved into a global pandemic resulting into a …

[HTML][HTML] Emerging pharmaceutical treatments of novel COVID-19: a review

A Hussain, J Kaler, AK Dubey - Cureus, 2020 - ncbi.nlm.nih.gov
As a new decade began, COVID-19 quickly gained importance as it became the cause of
the current global pandemic. Research has been focusing on studying the structure of SARS …

[PDF][PDF] A contemporary look at COVID-19 medications: available and potentially effective drugs

HK Alshaeri, ZS Natto - Eur Rev Med Pharmacol Sci, 2020 - researchgate.net
OBJECTIVE: There have been significant changes to the management of COVID-19 in
recent months, including protocols and guidelines designed to prevent, diagnose, and treat …

Current drugs with potential for treatment of COVID-19: A literature review: Drugs for the treatment process of COVID-19

MII Rabby - Journal of pharmacy & pharmaceutical …, 2020 - journals.library.ualberta.ca
Purpose: SARS-CoV-2 first emerged in China in December 2019 and rapidly spread
worldwide. No vaccine or approved drug is available to eradicate the virus, however, some …

COVID-19: A review of the proposed pharmacological treatments

S Lam, A Lombardi, A Ouanounou - European journal of pharmacology, 2020 - Elsevier
The emerging pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …

[PDF][PDF] A mini-review on the current COVID-19 therapeutic strategies

S Shafiee, S Davaran - Chemical Review and Letters, 2020 - chemrevlett.com
The coronavirus outbreak (COVID-19) started in china, on 31 December 2019. COVID-19 is
a severe acute respiratory syndrome. Research on COVID-19 treatment strategies for …

Potential drug candidates underway several registered clinical trials for battling COVID-19

F Mina, M Rahman, S Das, S Karmakar… - Authorea …, 2020 - essopenarchive.org
The emergence of new type of viral pneumonia cases in China, on December 31, 2019;
identified as the cause of human coronavirus, labeled as “COVID-19,” took a heavy toll of …